Barely Significant
← all excerpts

PD-L1/ITGB4 Axis Modulates Sensitivity of Hepatocellular Carcinoma to Sorafenib via FAK/AKT/mTOR Signaling Pathway.

Immunotargets Ther · 2025 · PMC12358154 · PMID 40827229

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

showed a trendp < 0.05actually significant
Furthermore, ITGB4 high patients showed a trend toward poorer survival (log-rank p < 0.05, Figure 4C ).

also in 33,226 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.